Literature DB >> 6296838

Abnormal adenosine-induced immunosuppression and cAMP metabolism in T lymphocytes of patients with systemic lupus erythematosus.

R Mandler, R E Birch, S H Polmar, G M Kammer, S A Rudolph.   

Abstract

Normal human T lymphocytes incubated with adenosine (10 muM) for 30 min at 37 degrees C show an increase in the percentage of cells expressing receptors for the Fc portion of IgG (RFc(gamma)) and the OKT8 antigen, while the proportion of OKT4(+) cells decreases. These effects occur exclusively in a subset of T cells with theophylline-resistant sheep erythrocyte receptors (T(R) cells) that is enriched for OKT4(+) cells. Untreated normal T(R) cells express helper/inducer cell activity for T-cell-dependent B-cell differentiation, while adenosine-treated T(R) cells suppress B-cell differentiation. In contrast, in T(R) cells isolated from patients with systemic lupus erythematosus (SLE), adenosine fails to induce immunosuppressor activity or to increase the percentage of OKT8(+) and RFc(gamma) (+) cells. In addition, although incubation of normal T(R) cells with adenosine causes a transient increase in cAMP levels (up to 160% of control within 5 min), in SLE T(R) cells, cAMP levels fall by 50% within 10 min. The photoaffinity label 8-azidoadenosine cyclic [(32)P]monophosphate has been used to show that human T lymphocytes have a single cAMP receptor site that appears to be the regulatory subunit of type I protein kinase. In normal T(R) cells, this receptor becomes occupied in response to adenosine. In contrast, in SLE T(R) cells, no change in cAMP receptor occupancy is detected. Although adenosine has a differential effect on normal and SLE T(R) cells, cAMP derivatives that can traverse the cell membrane (8-bromo- and 8-azidoadenosine cyclic monophosphates) induce an increase in the RFc(gamma) (+) cell subset in both normal and SLE T(R) cells. These results suggest that cAMP mediates the effects of adenosine on cell surface markers of T lymphocytes. The lack of an adenosine receptor-coupled adenylate cyclase activity in SLE T(R) cells may account, in part, for their lack of immunosuppressive activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6296838      PMCID: PMC347376          DOI: 10.1073/pnas.79.23.7542

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

Review 1.  Endogenous protein phosphorylation and dephosphorylation.

Authors:  S A Rudolph; B K Krueger
Journal:  Adv Cyclic Nucleotide Res       Date:  1979

Review 2.  Regulation of adenylate cyclase by adenosine.

Authors:  J N Fain; C C Malbon
Journal:  Mol Cell Biochem       Date:  1979-06-15       Impact factor: 3.396

3.  Immunoregulatory aberrations in systemic lupus erythematosus.

Authors:  A S Fauci; A D Steinberg; B F Haynes; G Whalen
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

Review 4.  Protein kinases.

Authors:  E G Krebs
Journal:  Curr Top Cell Regul       Date:  1972

5.  A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate.

Authors:  B L Brown; J D Albano; R P Ekins; A M Sgherzi
Journal:  Biochem J       Date:  1971-02       Impact factor: 3.857

6.  Cyclic nucleotide-dependent protein kinases. IV. Widespread occurrence of adenosine 3',5'-monophosphate-dependent protein kinase in various tissues and phyla of the animal kingdom.

Authors:  J F Kuo; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1969-12       Impact factor: 11.205

7.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

8.  Suppressor-cell dysfunction in systemic lupus erythematosus. Cells involved and in vitro correction.

Authors:  A Sagawa; N I Abdou
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

9.  Theophylline modulation of E-rosette formation: an indicator of T-cell maturation.

Authors:  S Limatibul; A Shore; H M Dosch; E W Gelfand
Journal:  Clin Exp Immunol       Date:  1978-09       Impact factor: 4.330

10.  Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.

Authors:  L Moretta; S R Webb; C E Grossi; P M Lydyard; M D Cooper
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  17 in total

1.  Anti-inflammatory or proinflammatory effect of an adenosine receptor agonist on the Th17 autoimmune response is inflammatory environment-dependent.

Authors:  Dongchun Liang; Aijun Zuo; Hui Shao; Mingjiazi Chen; Henry J Kaplan; Deming Sun
Journal:  J Immunol       Date:  2014-11-03       Impact factor: 5.422

Review 2.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

Review 3.  Pharmacological modification of immunoregulatory activity of lymphocytes: facts and potential.

Authors:  S H Polmar
Journal:  Surv Immunol Res       Date:  1984

4.  Covalent labelling of ligand binding sites of human placental S-adenosylhomocysteine hydrolase with 8-azido derivatives of adenosine and cyclic AMP.

Authors:  V N Aiyar; M S Hershfield
Journal:  Biochem J       Date:  1985-12-15       Impact factor: 3.857

5.  Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells.

Authors:  B N Cronstein; M A Eberle; H E Gruber; R I Levin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

6.  Defective cAMP-dependent phosphorylation of intact T lymphocytes in active systemic lupus erythematosus.

Authors:  P Hasler; L A Schultz; G M Kammer
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

7.  In vivo effects of a single infusion of theophylline on human peripheral blood lymphocytes.

Authors:  R Pardi; M R Zocchi; E Ferrero; G F Ciboddo; L Inverardi; C Rugarli
Journal:  Clin Exp Immunol       Date:  1984-09       Impact factor: 4.330

Review 8.  Adenosine in fibrosis.

Authors:  Edwin S L Chan; Bruce N Cronstein
Journal:  Mod Rheumatol       Date:  2009-12-01       Impact factor: 3.023

9.  Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes.

Authors:  G M Kammer; I U Khan; C J Malemud
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

10.  Impairment of lymphocyte suppressive system in recent onset insulin-dependent diabetes mellitus. Correlation with blood glucose and serum insulin levels.

Authors:  A Secchi; F Crosti; L Bonisolli; D Pavoni; F Capra; P Navone; A E Pontiroli; M Bellone; C Rugarli; G Pozza
Journal:  Acta Diabetol Lat       Date:  1989 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.